Related references
Note: Only part of the references are listed.Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention
Yan-Ruide Li et al.
STEM CELL RESEARCH & THERAPY (2022)
Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity
Yan-Ruide Li et al.
CANCERS (2022)
Current Concepts and Advances in Graft-Versus-Host Disease Immunology
Geoffrey R. Hill et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
Shoichi Iriguchi et al.
NATURE COMMUNICATIONS (2021)
Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies
Yan-Ruide Li et al.
CELLS (2021)
GVHD Prophylaxis 2020
Mahasweta Gooptu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
Yan-Ruid Li et al.
CELL REPORTS MEDICINE (2021)
Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD
Clint Piper et al.
BLOOD (2020)
The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus
Jakob R. Passweg et al.
BONE MARROW TRANSPLANTATION (2020)
Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
Florent Malard et al.
LEUKEMIA (2020)
Donor monocyte-derived macrophages promote human acute graft-versus-host disease
Laura Jardine et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Roles of NKT cells in cancer immunotherapy
Eun-Ah Bae et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Review of Graft-Versus-Host Disease
Vignesh Ramachandran et al.
DERMATOLOGIC CLINICS (2019)
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer
Yanni Zhu et al.
CELL STEM CELL (2019)
Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells
Amelie Montel-Hagen et al.
CELL STEM CELL (2019)
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression
Filippo Cortesi et al.
CELL REPORTS (2018)
The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach
Danielle Krijgsman et al.
FRONTIERS IN IMMUNOLOGY (2018)
CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
Lisa A. King et al.
FRONTIERS IN IMMUNOLOGY (2018)
Human CD4-invariant NKT lymphocytes regulate graft versus host disease
Tereza Coman et al.
ONCOIMMUNOLOGY (2018)
Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF-licensed myeloid cells
Sonia Tugues et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Pre-transplant donor CD4- invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease
M-T Rubio et al.
LEUKEMIA (2017)
Loss of natural killer T cells promotes pancreatic cancer in LSL-KrasG12D/+ mice
Naveena B. Janakiram et al.
IMMUNOLOGY (2017)
Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids
Christopher S. Seet et al.
NATURE METHODS (2017)
Progenitor T-cell differentiation from hematopoietic stem cells using Delta-like-4 and VCAM-1
Shreya Shukla et al.
NATURE METHODS (2017)
Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective
Amrendra Kumar et al.
FRONTIERS IN IMMUNOLOGY (2017)
Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
Melissa Mavers et al.
Frontiers in Immunology (2017)
Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis
Francesca Gorini et al.
BLOOD (2017)
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality
Dominik Schneidawind et al.
BLOOD (2015)
Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells
Drake J. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells
Dominik Schneidawind et al.
BLOOD (2014)
Technical Advance: Ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of stromal cells
Mirelle J. A. J. Huijskens et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Thymic Damage, Impaired Negative Selection, and Development of Chronic Graft-versus-Host Disease Caused by Donor CD4+ and CD8+ T Cells
Tao Wu et al.
JOURNAL OF IMMUNOLOGY (2013)
Allelic Exclusion and Peripheral Reconstitution by TCR Transgenic T Cells Arising From Transduced Human Hematopoietic Stem/Progenitor Cells
Francesca Giannoni et al.
MOLECULAR THERAPY (2013)
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
Maria Themeli et al.
NATURE BIOTECHNOLOGY (2013)
NKT cells as an ideal anti-tumor immunotnerapeutic
Shin-ichiro Fujii et al.
FRONTIERS IN IMMUNOLOGY (2013)
Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions
Patrick J. Brennan et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival
Marie-Therese Rubio et al.
BLOOD (2012)
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
Aristeidis Chaidos et al.
BLOOD (2012)
Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory Phenotype
Niwa Ali et al.
PLOS ONE (2012)
Invariant natural killer T cells: bridging innate and adaptive immunity
Luc Van Kaer et al.
CELL AND TISSUE RESEARCH (2011)
Mouse models of graft-versus-host disease: advances and limitations
Mark A. Schroeder et al.
DISEASE MODELS & MECHANISMS (2011)
Update on Therapy of Chronic Lymphocytic Leukemia
John G. Gribben et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors
Holbrook E. Kohrt et al.
BLOOD (2009)
The role of B cells in the pathogenesis of graft-versus-host disease
Alexander Shimabukuro-Vornhagen et al.
BLOOD (2009)
Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex
M. A. King et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
V alpha 24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
Liping Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Acute GvHD: pathogenesis and classification
L. M. Ball et al.
BONE MARROW TRANSPLANTATION (2008)
Control points in NKT-cell development
Dale I. Godfrey et al.
NATURE REVIEWS IMMUNOLOGY (2007)
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukeryiia
Ronjon Chakraverty et al.
BLOOD (2007)
Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation
Asha B. Pillai et al.
JOURNAL OF IMMUNOLOGY (2007)
The graft content of donor T cells expressing γδTCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors
Caroline Pabst et al.
CLINICAL CANCER RESEARCH (2007)
Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation
Dominik Wolf et al.
TRANSPLANTATION (2007)
Humanized mice in translational biomedical research
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation
Ping Lan et al.
BLOOD (2006)
Protective conditioning for acute graft-versus-host disease
R Lowsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ
BE Anderson et al.
BLOOD (2005)
Toward an understanding of NKT cell biology: Progress and paradoxes
M Kronenberg
ANNUAL REVIEW OF IMMUNOLOGY (2005)
Recovery of Vα24 NKT cells after hematopoietic stem cell transplantation
K Haraguchi et al.
BONE MARROW TRANSPLANTATION (2004)
CD1: Antigen presentation and T cell function
M Brigl et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Influence of transplanted dose of CD56+cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors
S Yamasaki et al.
BONE MARROW TRANSPLANTATION (2003)
Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: The role of CD1-reactive natural killer T cells
FS Lan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Predominance of NK1.1+TCRαβ+ or DX5+TCRαβ+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease:: Natural suppressor cells
FS Lan et al.
JOURNAL OF IMMUNOLOGY (2001)
Haematopoietic cell transplantation as immunotherapy
FR Appelbaum
NATURE (2001)
Share Paper
